“Changes in the Concentration of EGFR-Mutated Plasma DNA in the First Hours of Anti-EGFR Therapy Allow the Prediction of Tumor Response in Patients With EGFR-Driven Lung Cancer”. Voprosy onkologii 67, no. 5 (October 29, 2021): 665–674. Accessed October 14, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/1292.